Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0690
Full Text
Open PDFAbstract
Available in full text
Date
December 15, 2004
Authors
Publisher
American Association for Cancer Research (AACR)